Kindred Biosciences (KIN) – Corporate News
-
Elanco (ELAN) Announces Agreement to Acquire Kindred Biosciences (KIN) for $9.25 Per Share
-
Kindred Biosciences (KIN) Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody for the Prevention of Deaths in Dogs Infected by Parvovirus
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to KIN Stock Lookup